Auxilium says Endo's offer "significantly undervalues" company

Mon Sep 22, 2014 7:25am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 22 (Reuters) - Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's offer "significantly undervalues" the company.

Endo made an unsolicited offer last week to buy Auxilium for about $2.2 billion.

Auxilium's board also reiterated on Monday that it backed the company's offer to buy Canadian eye drug maker QLT Inc . (Reporting by Ankur Banerjee in Bangalore; Editing by Kirti Pandey)